Structural Biology Lab, Centre for Biomedical Research, SBST, VIT University, Vellore, India.
Nutr Metab (Lond). 2011 Jun 29;8(1):46. doi: 10.1186/1743-7075-8-46.
α-glucosidase inhibitors regulate postprandial hyperglycemia (PPHG) by impeding the rate of carbohydrate digestion in the small intestine and thereby hampering the diet associated acute glucose excursion. PPHG is a major risk factor for diabetic vascular complications leading to disabilities and mortality in diabetics. Cinnamomum zeylanicum, a spice, has been used in traditional medicine for treating diabetes. In this study we have evaluated the α-glucosidase inhibitory potential of cinnamon extract to control postprandial blood glucose level in maltose, sucrose loaded STZ induced diabetic rats.
The methanol extract of cinnamon bark was prepared by Soxhlet extraction. Phytochemical analysis was performed to find the major class of compounds present in the extract. The inhibitory effect of cinnamon extract on yeast α-glucosidase and rat-intestinal α-glucosidase was determined in vitro and the kinetics of enzyme inhibition was studied. Dialysis experiment was performed to find the nature of the inhibition. Normal male Albino wistar rats and STZ induced diabetic rats were treated with cinnamon extract to find the effect of cinnamon on postprandial hyperglycemia after carbohydrate loading.
Phytochemical analysis of the methanol extract displayed the presence of tannins, flavonoids, glycosides, terpenoids, coumarins and anthraquinones. In vitro studies had indicated dose-dependent inhibitory activity of cinnamon extract against yeast α-glucosidase with the IC 50 value of 5.83 μg/ml and mammalian α-glucosidase with IC 50 value of 670 μg/ml. Enzyme kinetics data fit to LB plot pointed out competitive mode of inhibition and the membrane dialysis experiment revealed reversible nature of inhibition. In vivo animal experiments are indicative of ameliorated postprandial hyperglycemia as the oral intake of the cinnamon extract (300 mg/kg body wt.) significantly dampened the postprandial hyperglycemia by 78.2% and 52.0% in maltose and sucrose loaded STZ induced diabetic rats respectively, compared to the control. On the other hand, in rats that received glucose and cinnamon extract, postprandial hyperglycemia was not effectively suppressed, which indicates that the observed postprandial glycemic amelioration is majorly due to α-glucosidase inhibition.
The current study demonstrates one of the mechanisms in which cinnamon bark extract effectively inhibits α-glucosidase leading to suppression of postprandial hyperglycemia in STZ induced diabetic rats loaded with maltose, sucrose. This bark extract shows competitive, reversible inhibition on α-glucosidase enzyme. Cinnamon extract could be used as a potential nutraceutical agent for treating postprandial hyperglycemia. In future, specific inhibitor has to be isolated from the crude extract, characterized and therapeutically exploited.
α-葡萄糖苷酶抑制剂通过抑制小肠中碳水化合物的消化速率来调节餐后高血糖(PPHG),从而阻碍与饮食相关的急性血糖波动。PPHG 是导致糖尿病患者发生血管并发症导致残疾和死亡的主要危险因素。肉桂,一种香料,已在传统医学中用于治疗糖尿病。在这项研究中,我们评估了肉桂提取物对控制麦芽糖、蔗糖负荷 STZ 诱导的糖尿病大鼠餐后血糖水平的α-葡萄糖苷酶抑制潜力。
采用索氏提取法从肉桂树皮中提取甲醇提取物。进行植物化学分析以确定提取物中存在的主要化合物类别。在体外测定肉桂提取物对酵母α-葡萄糖苷酶和大鼠肠α-葡萄糖苷酶的抑制作用,并研究酶抑制的动力学。进行透析实验以确定抑制的性质。用肉桂提取物治疗正常雄性白化 Wistar 大鼠和 STZ 诱导的糖尿病大鼠,以研究肉桂对碳水化合物负荷后餐后高血糖的影响。
甲醇提取物的植物化学分析显示存在单宁、类黄酮、糖苷、萜类、香豆素和蒽醌。体外研究表明,肉桂提取物对酵母α-葡萄糖苷酶具有剂量依赖性抑制活性,IC 50 值为 5.83μg/ml,对哺乳动物α-葡萄糖苷酶的 IC 50 值为 670μg/ml。酶动力学数据拟合 LB 图表明抑制方式为竞争性,膜透析实验表明抑制为可逆性。体内动物实验表明,肉桂提取物(300mg/kg 体重)可改善餐后高血糖,与对照组相比,麦芽糖和蔗糖负荷 STZ 诱导的糖尿病大鼠的餐后高血糖分别降低了 78.2%和 52.0%。另一方面,在接受葡萄糖和肉桂提取物的大鼠中,餐后高血糖并未得到有效抑制,这表明观察到的餐后血糖改善主要是由于α-葡萄糖苷酶抑制所致。
本研究表明,肉桂树皮提取物通过有效抑制α-葡萄糖苷酶来抑制 STZ 诱导的糖尿病大鼠麦芽糖、蔗糖负荷后的餐后高血糖,其机制之一。该树皮提取物对α-葡萄糖苷酶表现出竞争性、可逆性抑制。肉桂提取物可作为治疗餐后高血糖的潜在营养保健品。未来,必须从粗提物中分离、表征和治疗利用特定抑制剂。